Back to Search
Start Over
Uric acid inhibits HMGB1-TLR4-NF-κB signaling to alleviate oxygen-glucose deprivation/reoxygenation injury of microglia.
- Source :
-
Biochemical and biophysical research communications [Biochem Biophys Res Commun] 2021 Feb 12; Vol. 540, pp. 22-28. Date of Electronic Publication: 2021 Jan 09. - Publication Year :
- 2021
-
Abstract
- Mounting evidence has implicated inflammation in ischemia-reperfusion injury following acute ischemic stroke (AIS). Microglia remain the primary initiator and participant of brain inflammation. Emerging evidence has indicated that uric acid has promise for the treatment of AIS, but its explicit mechanisms remain elusive. Here, we observed that uric acid reduced the severity of cerebral infarction and attenuated the activation of microglia in the cerebral cortex in a mouse middle cerebral-artery occlusion/reperfusion model. Thus, we speculated that uric acid may play a role by directly interfering with the inflammatory response of microglia. First, we investigated whether the HMGB1-TLR4-NF-κB signaling plays a role in oxygen glucose deprivation and reperfusion (OGD/R) injury of BV2 cells. Inhibition of the signaling significantly reduced the release of the proinflammatory cytokines tumor necrosis factor α (TNF-α), interleukin 1β (IL1β), and IL6 caused by OGD/R in BV2 cells. Second, uric acid weakened the decreased cell viability and lactate dehydrogenase release induced by OGD/R in BV2 cells. Finally, uric acid reduced the release of the proinflammatory cytokines TNF-α, IL1β, and IL6 caused by OGD/R in BV2 cells by dampening HMGB1-TLR4-NF-κB signaling, which was reversed by probenecid treatment, an inhibitor of the uric acid channel. Hence, uric acid halted the release of inflammatory factors and the decreased cell viability induced by ODG/R via inhibiting the microglia HMGB1-TLR4-NF-κB signaling, thereby alleviating the damage to microglia. This may be part of the molecular mechanisms by which uric acid protects mice against the brain damage of middle cerebral-artery occlusion/reperfusion.<br />Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.<br /> (Copyright © 2021 Elsevier Inc. All rights reserved.)
- Subjects :
- Animals
Cell Line
Cell Survival
Disease Models, Animal
HMGB1 Protein metabolism
Inflammation drug therapy
Inflammation Mediators metabolism
Ischemic Stroke pathology
Male
Mice
Mice, Inbred C57BL
Microglia metabolism
Microglia pathology
NF-kappa B metabolism
Oxygen metabolism
Probenecid pharmacology
Signal Transduction drug effects
Toll-Like Receptor 4 metabolism
Uric Acid metabolism
Cell Hypoxia drug effects
Glucose metabolism
Ischemic Stroke drug therapy
Ischemic Stroke metabolism
Microglia drug effects
Uric Acid pharmacology
Uric Acid therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 1090-2104
- Volume :
- 540
- Database :
- MEDLINE
- Journal :
- Biochemical and biophysical research communications
- Publication Type :
- Academic Journal
- Accession number :
- 33429196
- Full Text :
- https://doi.org/10.1016/j.bbrc.2020.12.097